We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.77%
4 Financials 5.47%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EL icon
276
PUT
Estee Lauder
EL
$36.9B
$96.3M 0.08%
658,200
+137,500
+26% +$18.2M
DAL icon
277
PUT
Delta Air Lines
DAL
$54.2B
$96.2M 0.08%
2,392,200
+582,400
+32% +$21.1M
BMY icon
278
CALL
Bristol-Myers Squibb
BMY
$137B
$96.2M 0.08%
1,874,400
-1,033,700
-36% -$54.3M
INCY icon
279
Incyte
INCY
$25.9B
$94.2M 0.08%
1,501,024
-175,346
-10% -$9.92M
ZM icon
280
PUT
Zoom
ZM
$31.5B
$92.7M 0.08%
1,289,000
+64,900
+5% +$4.29M
CHTR icon
281
CALL
Charter Communications
CHTR
$17.9B
$92.2M 0.08%
237,200
+8,700
+4% +$3.55M
XP icon
282
XP
XP
$8.53B
$92M 0.08%
3,529,440
+2,033,401
+136% +$46.4M
CTVA icon
283
Corteva
CTVA
$54.6B
$91.9M 0.08%
1,917,790
+272,568
+17% +$13M
FICO icon
284
PUT
Fair Isaac
FICO
$25.3B
$91.8M 0.08%
78,900
-2,500
-3% -$2.52M
PYPL icon
285
PayPal
PYPL
$52.7B
$91.8M 0.08%
1,494,373
-207,950
-12% -$11.9M
USB icon
286
PUT
US Bancorp
USB
$96.7B
$91.6M 0.08%
2,116,200
+178,200
+9% +$6.51M
PFE icon
287
CALL
Pfizer
PFE
$160B
$91M 0.08%
3,161,600
+1,418,500
+81% +$42.9M
XYZ
288
Block Inc
XYZ
$49.4B
$90.9M 0.08%
1,175,035
+960,006
+446% +$54.3M
TJX icon
289
TJX Companies
TJX
$155B
$90.8M 0.08%
968,119
-2,573,794
-73% -$231M
FOXA icon
290
Fox Class A
FOXA
$28.8B
$90.4M 0.08%
3,045,876
+130,512
+4% +$3.95M
LMT icon
291
CALL
Lockheed Martin
LMT
$130B
$89.2M 0.08%
196,800
+14,800
+8% +$6.56M
MDB icon
292
CALL
MongoDB
MDB
$34.7B
$88.9M 0.08%
217,400
+900
+0.4% +$341K
DE icon
293
CALL
Deere & Co
DE
$175B
$88.4M 0.08%
221,000
-29,600
-12% -$11.2M
RCL icon
294
CALL
Royal Caribbean
RCL
$78.1B
$87.9M 0.08%
679,200
+67,800
+11% +$6.91M
FIS icon
295
Fidelity National Information Services
FIS
$21.3B
$87.9M 0.08%
1,463,291
+262,722
+22% +$14.4M
FSLR icon
296
CALL
First Solar
FSLR
$23B
$87.8M 0.08%
509,500
-112,500
-18% -$17.2M
NTAP icon
297
NetApp
NTAP
$37.7B
$87.6M 0.08%
993,219
+760,112
+326% +$61.2M
SFM icon
298
Sprouts Farmers Market
SFM
$7.56B
$86.8M 0.08%
1,803,767
+148,169
+9% +$6.48M
RUN icon
299
Sunrun
RUN
$2.21B
$86.7M 0.08%
4,414,764
+4,049,075
+1,107% +$51.4M
VRTX icon
300
Vertex Pharmaceuticals
VRTX
$139B
$86.7M 0.08%
212,981
-44,012
-17% -$16.3M

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.